Mon panier

PE-Labeled Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Tetramer Protein

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
HLC-HP2H3-25ug
$410.00
HLC-HP2H3-200ug (100ug X 2)
$2350.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    HLA-A*0201 & B2M & EBV EBNA3C (LLDFVRFMGV)

  • Source

    PE-Labeled Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Tetramer Protein (HLC-HP2H3) is expressed from human 293 cells (HEK293). It contains AA Gly 25 - Ile 308 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & LLDFVRFMGV peptide (Accession # AAA59606.1 (HLA-A*02:01) & P61769-1 (B2M) & LLDFVRFMGV).

    Predicted N-terminus: Gly 25 & Leu

    Request for sequence
  • Molecular Characterization

    PE-Labeled Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Tetramer Protein is assembled by biotinylated monomer (HLC-H82E8) and PE-labeled streptavidin.

    Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein is produced by co-expression of HLA and B2M loaded with EBV EBNA3C peptide. Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

  • Conjugate

    PE

    Excitation Wavelength: 488 nm / 561 nm

    Emission Wavelength: 575 nm

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, 1% BSA, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please protect from light and avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Avis des utilisateurs
Publier un commentaire

Introduction de fond

The peptide LLDFVRFMGV, derived from the Epstein-Barr virus nuclear antigen EBNA3C, is presented by the HLA-A*02:01/β2m complex. This peptide-MHC complex serves as a major target for cytotoxic T lymphocytes (CTLs) in the immune control of EBV infection. Its robust immunogenicity makes it a key antigen of interest for studying EBV-specific T-cell responses and for developing immunotherapies against EBV-associated diseases.

Progrès de frontière

 
Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Avis des utilisateurs
  • Contexte